Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Meeting With Management
Tweet
Share
E-mailGet Alerts OSUR Hot Sheet
Price: $3.88 +3.74%
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.
Analyst, Jeffrey Frelick, said, "OSUR is making good progress training its selling partners. OraQuick HCV training has included 100 Merck sales specialists, and soon to follow will be 120 Merck inside sales reps. Physician office distributor Henry Schein (Nasdaq: HSIC) has been trained on OraQuick HCV, with PSS and McKesson to follow."
"HCV funding good, but looking for more. In 2012, the CDC’s division of Viral Hepatitis funding was approximately $19M, with an additional $10M for HCV screening. OSUR believes the CDC will look to increase the budget in 2013 to ~$60M."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $10.46 yesterday.
Analyst, Jeffrey Frelick, said, "OSUR is making good progress training its selling partners. OraQuick HCV training has included 100 Merck sales specialists, and soon to follow will be 120 Merck inside sales reps. Physician office distributor Henry Schein (Nasdaq: HSIC) has been trained on OraQuick HCV, with PSS and McKesson to follow."
"HCV funding good, but looking for more. In 2012, the CDC’s division of Viral Hepatitis funding was approximately $19M, with an additional $10M for HCV screening. OSUR believes the CDC will look to increase the budget in 2013 to ~$60M."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $10.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
